IDiyas

For the Inventor, By the Inventor

North Andover, MA, United States of America

Mikhail Smirnov

USPTO Granted Patents = 13 

 

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal13 out of 50 
 
Avedro, Inc.
 patents

Years Active: 2019-2025

Loading Chart...
Loading Chart...
13 patents (USPTO):
1. 12427062 - Systems and methods for cross-linking treatments of an eye (2025-09-30),
2. 12293513 - Systems and methods for generating patient-specific corneal cross-linking treatment patterns (2025-05-06),
3. 12171691 - Systems and methods for cross-linking treatments of an eye (2024-12-24),
4. 12070618 - Systems and methods for photoactivating a photosensitizer applied to an eye (2024-08-27),
5. 12042433 - Systems and methods for eye tracking during eye treatment (2024-07-23),
6. 12004811 - Systems and methods for determining cross-linking distribution in a cornea and/or structural characteristics of a cornea (2024-06-11),
7. 11642244 - Photoactivation systems and methods for corneal cross-linking treatments (2023-05-09),
8. 11529050 - Systems and methods for determining cross-linking distribution in a cornea and/or structural characteristics of a cornea (2022-12-20),
9. 11219553 - Systems and methods for cross-linking treatments of an eye (2022-01-11),
10. 11167149 - Systems and methods for photoactivating a photosensitizer applied to an eye (2021-11-09),
11. 10631726 - Systems and methods for determining cross-linking distribution in a cornea and/or structural characteristics of a cornea (2020-04-28),
12. 10350111 - Systems and methods for cross-linking treatments of an eye (2019-07-16),
13. 10258809 - Systems and methods for photoactivating a photosensitizer applied to an eye (2019-04-16),

Title: Mikhail Smirnov: Innovator in Corneal Treatment Technologies

Introduction

Mikhail Smirnov is a prominent inventor based in North Andover, MA (US), known for his significant contributions to the field of ophthalmology. With a total of 13 patents to his name, he has developed innovative systems and methods that enhance corneal treatments, particularly for conditions such as keratoconus.

Latest Patents

Among his latest patents is a system designed for cross-linking treatments of the eye. This system includes a light source that activates cross-linking in selected regions of the cornea treated with a cross-linking agent. The light source delivers photoactivating light according to a set of parameters, while a controller processes input related to the cross-linking agent and parameters. The controller utilizes program instructions to calculate the amount of cross-linking and adjusts the light source accordingly.

Another notable patent involves generating patient-specific corneal cross-linking treatment patterns. This automated process receives tomographic data and creates an optimized treatment pattern tailored to individual patients, eliminating the need for physician analysis. The method identifies keratoconic defects and segments them into treatment zones for effective application of the cross-linking agent.

Career Highlights

Mikhail Smirnov is currently associated with Avedro, Inc., a company that focuses on advancing corneal cross-linking technologies. His work has significantly impacted the way corneal treatments are approached, providing more precise and effective solutions for patients.

Collaborations

Throughout his career, Mikhail has collaborated with notable professionals in the field, including Marc David Friedman and Pavel Kamaev. These collaborations have further enriched his work and contributed to the development of innovative treatment methods.

Conclusion

Mikhail Smirnov's contributions to corneal treatment technologies exemplify the impact of innovation in healthcare. His patents reflect a commitment to improving patient outcomes through advanced medical solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…